Tenivac

TENIVAC® is a vaccine indicated for active immunization for the prevention of tetanus and diphtheria in persons 7 years of age and older.

Tenivac is a vaccine used for the prevention of tetanus (lockjaw) and diphtheria in persons 7 years of age and older.

Tenivac vaccine is used:

• in persons who have not been immunized previously against tetanus and diphtheria
• as a routine booster immunization against tetanus and diphtheria
• for post-exposure diphtheria prevention
• for active tetanus immunization in wound management

Tenivac is part of the drug class:

• diphtheria toxoid

Tell your healthcare provider if you or your child:

• had a severe allergic reaction (e.g., anaphylaxis) after a previous dose of Tenivac vaccine or any other tetanus toxoid or diphtheria toxoid-containing vaccine or any other component of this vaccine
• are pregnant or plan to become pregnant
• are breastfeeding
• are allergic to latex

Tell you doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. 

Tell your doctor is you are breastfeeding or plan to breastfeed. 

It is not known if Tenivac crosses into human milk. Because some vaccines can cross into human milk and because of the possibility for serious adverse reactions in nursing infants with use of this vaccine, a choice should be made whether to stop nursing or stop the use of this vaccine. Your doctor and you will decide if the benefits outweigh the risk of using Tenivac.

Tenivac is a vaccine given as a shot by your healthcare provider. 

• In persons who have not been immunized previously against tetanus and diphtheria, primary immunization with Tenivac vaccine consists of three 0.5 mL doses. The first 2 doses are administered 2 months apart and the third dose is administered 6-8 months after the second dose.
• Tenivac vaccine may be used for routine booster immunization against tetanus and diphtheria in persons 7 years of age and older. Routine booster immunization against tetanus and diphtheria is recommended in children 11-12 years of age and every 10 years thereafter.
• Tenivac vaccine may be used for post-exposure diphtheria prevention in persons 7 years of age and older who have not completed primary vaccination, whose vaccination status is unknown, or who have not been vaccinated with diphtheria toxoid within the previous 5 years. Consult recommendations of the Advisory Committee on Immunization Practices for additional interventions for diphtheria prophylaxis in close contacts of diphtheria patients
• Tenivac vaccine is approved for wound management of patients 7 years of age and older.The need for active immunization with a tetanus toxoid-containing preparation, with or without passive immunization with Tetanus Immune Globulin (TIG) (Human) depends on both the condition of the wound and the patient's vaccination history.

Tenivac is administered by a healthcare provider in a medical setting. It is unlikely that an overdose will occur in this setting. However, if overdoes is suspected, seek emergency medical attention. 

Diphtheria and tetanus vaccine is a combination vaccine that is given to protect against infections caused by diphtheria and tetanus (lockjaw). The vaccine works by causing the body to produce its own protection (antibodies) against these diseases. This vaccine is given to children 6 weeks of age and older, teenagers, and adults.

Diphtheria is a serious illness that can cause breathing problems, heart problems, nerve damage, pneumonia, and possibly death. The risk for serious illness is greater in very young children and the elderly.

Tetanus (also known as lockjaw) is a very serious illness that causes severe muscle spasms that make the muscles very rigid or stiff. The muscle spasms can be strong enough to cause bone fractures in the spine. The disease can also cause breathing problems, swallowing problems, seizures, and possibly death.

This vaccine is to be administered only by or under the direct supervision of a doctor.

It is very important that you or your child return to your doctor’s office at the right time for the next dose. Be sure to notify your doctor of any unwanted effects that occur after you receive the vaccine.

If you or your child develop a skin rash, hives, or any allergic reaction after receiving this vaccine, tell your doctor right away.

Tell your doctor right away if you or your child are allergic to latex rubber. The prefilled syringes or bottle of vaccine may contain natural rubber latex. This may cause an allergic reaction in patients who are sensitive to latex.

This vaccine will not treat an active infection. If you or your child have an infection due to diphtheria or tetanus, you will need medicine to treat the infection.

• Tell all of your health care providers that you take Tenivac. This includes your doctors, nurses, pharmacists, and dentists.
• This medicine may not protect all people who use it. Talk with the doctor.
• If you have a latex allergy, talk with your doctor.
• Not all brands of vaccines are for all children. Talk with your child's doctor.
• Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this medicine while you are pregnant.
• Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.

Storage

Parenteral

2–8°C.112 113 114 Do not freeze; discard if freezing occurs.112 113 114